Ramin Massoumi
Overview
Explore the profile of Ramin Massoumi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
69
Citations
1720
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saamarthy K, Daams R, Sime W, Persson C, Chygorin E, Ahlqvist K, et al.
Br J Pharmacol
. 2025 Feb;
PMID: 39943627
Background And Purpose: Malignant melanoma is the most lethal form of skin cancer, characterised by a poor survival rate. One of the key factors driving the aggressive growth of melanoma...
2.
Daams R, Tran T, Jemaa M, Sime W, Mickeviciute R, Ek S, et al.
Cell Death Dis
. 2024 Sep;
15(9):690.
PMID: 39327470
The t(14;19)(q32;q13) is a rare recurring translocation found in B-cell lymphoproliferative malignancies, involving the Bcl-3 gene. This chromosomal translocation is often found in patients under the age of 50 and...
3.
4.
Bjorklund M, Massoumi R, Ohlsson B
BMC Med Educ
. 2024 Jan;
24(1):75.
PMID: 38245755
Background: Medical student master's theses are often carried out as research projects, and some are published as research papers in journals. We investigated the percentage of master's theses conducted by...
5.
Saamarthy K, Ahlqvist K, Daams R, Balagunaseelan N, Rinaldo-Matthis A, Kazi J, et al.
BMC Cancer
. 2024 Jan;
24(1):103.
PMID: 38238702
Molecular targeted therapy using a drug that suppresses the growth and spread of cancer cells via inhibition of a specific protein is a foundation of precision medicine and treatment. High...
6.
Mehrabadi A, Shahba F, Khorramdelazad H, Aghamohammadi N, Karimi M, Bagherzadeh K, et al.
Crit Rev Oncol Hematol
. 2023 Nov;
193:104200.
PMID: 37981104
IL-1, plays a role in some pathological inflammatory conditions. This pro-inflammatory cytokine also has a crucial role in tumorigenesis and immune responses in the tumor microenvironment (TME). IL-1 receptor accessory...
7.
Jemaa M, Daams R, Charfi S, Mertens F, M Huber S, Massoumi R
Int J Mol Sci
. 2023 Sep;
24(18).
PMID: 37762227
Polyploidy and metastasis are associated with a low probability of disease-free survival in cancer patients. Polyploid cells are known to facilitate tumorigenesis. However, few data associate polyploidization with metastasis. Here,...
8.
Shah K, Nasimian A, Ahmed M, Al Ashiri L, Denison L, Sime W, et al.
Blood Cancer J
. 2023 Sep;
13(1):139.
PMID: 37679323
The deregulation of BCL2 family proteins plays a crucial role in leukemia development. Therefore, pharmacological inhibition of this family of proteins is becoming a prevalent treatment method. However, due to...
9.
Griewahn L, Muller-Foxworth M, Peintner L, Wissler M, Weiss M, Brauns-Schubert P, et al.
Cell Rep
. 2023 Jan;
42(1):111961.
PMID: 36640323
SPATA2 mediates the recruitment of CYLD to immune receptor complexes by bridging the interaction of CYLD with the linear ubiquitylation assembly complex (LUBAC) component HOIP. Whether SPATA2 exhibits functions independently...
10.
Serrano S, Tavecchio M, Mallik J, Gronberg A, Elmer E, Kifagi C, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230472
Hepatocellular carcinoma (HCC), commonly diagnosed at an advanced stage, is the most common primary liver cancer. Owing to a lack of effective HCC treatments and the commonly acquired chemoresistance, novel...